A case of 5-fluorouracil-induced peripheral neuropathy

Clinical Toxicology

Volumn 46, Issue 3, 2008, Pages 264-266

  Werbrouck, Bart F ^a   Pauwels, Walter J ^b   De Bleecker, Jan L ^a,b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b Algemeen Ziekenhuis Sint Lucas Gent   (Belgium)

Author keywords

5 fluorouracil; A waves; Chemotherapy; Peripheral neuropathy; Rectal neoplasm

Indexed keywords

FLUOROURACIL;

A WAVE; ADULT; ARTICLE; CANCER STAGING; CARDIOTOXICITY; CASE REPORT; DIARRHEA; DRUG SAFETY; ELECTROENCEPHALOGRAM; FEMALE; HAND FOOT SYNDROME; HUMAN; LEUKOPENIA; MUCOSA INFLAMMATION; NAUSEA; NERVE FIBER DEGENERATION; NEUROTOXICITY; PERIPHERAL NEUROPATHY; RECTUM CANCER; SENSORIMOTOR FUNCTION; SENSORIMOTOR NEUROPATHY; THROMBOCYTOPENIA; VOMITING;

ADENOCARCINOMA; ANTIMETABOLITES, ANTINEOPLASTIC; ELECTROMYOGRAPHY; FEMALE; FLUOROURACIL; HUMANS; LOWER EXTREMITY; MIDDLE AGED; NEUROLOGIC EXAMINATION; PERIPHERAL NERVOUS SYSTEM DISEASES; PERONEAL NERVE; RECTAL NEOPLASMS; TIBIAL NERVE;

EID: 40849119791     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.1080/15563650701438763     Document Type: Article

References (11)

1. Van Kuilenburg AB. Dihydropyrimidine dehydrogenase and the efficacy and toxicity of 5-fluorouracil. European Journal of Cancer 2004; 40:939-950.
2. Teixeira L, Barry S, Debourdeau P, Cohen A, Tournigand C. Cardiotoxicity of 5-fluorouracil. Bulletin du Cancer 2004; 91:154-158.
3. Stein ME, Drumea K, Yarnitsky D, Benny A, Tzuk-Shina T. A rare event of 5-fluorouracil-associated peripheral neuropathy: a report of two patients. American Journal of Clinical Oncology 1998; 21:248-249.
4. Sucker C, Lambers C, Stockschlader M, Dolken G. Neurotoxicity of 5-fluorouracil. Deutsche medizinische Wochenschrift 2002; 127:2011-2014.
5. Saif MW, Wilson RH, Harold N, Keith B, Dougherty DS, Grem JL. Peripheral neuropathy associated with weekly oral 5-fluorouracil, leucovorin and eniluracil. Anti-cancer Drugs 2001; 12:525-531.
6. Van Laarhoven HW, Verstappen CC, Beex LV, Kappelle AC, Punt CJ. 5-FU-induced peripheral neuropathy: a rare complication of a well-known drug. Anticancer Research 2003; 23:647-648.
7. Saletti P, Pagani O, Sessa C, Goldhirsch A. Two cases of neurotoxicity possibly related to 5-fluorouracil and FA administration. Annals of Oncology 1996; 7:213-214.
8. Shehata N, Pater A, Tang SC. Prolonged severe 5-fluorouracil-associated neurotoxicity in a patient with dihydropyrimidine dehydrogenase deficiency. Cancer Investigation 1999; 17:201-205.
9. Takimoto CH, Lu ZH, Zhang R, Liang MD, Larson LV, Cantilena LR. Severe neurotoxicity following 5-fluorouracil-based chemotherapy in a patient with dihydropyrimidine dehydrogenase deficiency. Clinical Cancer Research 1996; 2:477-481.
10. Delval L, Klastersky J. Optic neuropathy in cancer patients. Report of a case possibly related to 5-fluorouracil toxicity and review of the literature. Journal of Neuro-oncology 2002; 60:165-169.
11. Rowin J, Meriggioli MN. Electrodiagnostic significance of supramaximally stimulated A-waves. Muscle & Nerve 2000; 23:1117-1120.